A Safety Study Assessing Oral Anticoagulation with Apixaban versus Vitamin-
K Antagonists in Patients with Atrial Fibrillation and End-Stage Kidney Disease
(ESKD) on Chronic Hemodialysis Treatment

EudraCT no. 2015-005503-84

Studienkoordinator:
Prof. Dr. med. Holger Reinecke, Münster

Beteiligte Wissenschaftler:
Akad. Rat Dr. Dipl.-Stat. J. Gerß
Dr. rer. nat. Dennis Görlich